Suboptimal Response to Induction Therapy May Predict Poor Survival

Product Description

Outcomes of patients with primary refractory multiple myeloma in the era of triplet and quadruplet induction therapy - ScienceDirect

Treatment-related toxicities after induction therapy.

Impact of response after induction and consolidation phases of

Cancers, Free Full-Text

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis - Biology of Blood and Marrow Transplantation

Frontiers The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions

JCM, Free Full-Text

Cancers, Free Full-Text

Cancer immunotherapy: it's time to better predict patients' response

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Long-Term Survival after Kidney Transplantation

Cancers, Free Full-Text

A) Duration of response (DoR). (B) Overall survival (OS) in patients